XML 156 R127.htm IDEA: XBRL DOCUMENT v3.20.4
Parent Company Only Condensed Financial Information - Schedule of Condensed Statements of Cash Flows (Detail) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating activities:      
Net income $ 32,192,000 $ 33,878,000 $ 14,139,000
Adjustment to reconcile net income to net cash from operating activities:      
Net cash from operating activities 32,207,000 39,328,000 19,625,000
Cash flows used for investing activities:      
Proceeds from sale of premises and equipment 12,000 2,000 1,190,000
Acquisition, net of cash acquired     143,797,000
Net cash used for investing activities (340,022,000) (150,311,000) (33,786,000)
Cash flows from financing activities:      
Payment to repurchase series B preferred stock   (402,000)  
Net cash from financing activities 398,802,000 116,739,000 16,421,000
CBI[Member]      
Operating activities:      
Net income 32,192,000 33,878,000 14,139,000
Adjustment to reconcile net income to net cash from operating activities:      
Change in other assets and other liabilities 1,925,000 4,437,000 794,000
Gain on sale of fixed assets     (110,000)
Equity in undistributed net earnings of subsidiaries (18,188,000) (22,438,000) (15,987,000)
Net cash from operating activities 15,929,000 15,877,000 (1,164,000)
Cash flows used for investing activities:      
Proceeds from sale of premises and equipment     899,000
Disposal of investment in subsidiary   41,000  
Acquisition, net of cash acquired     (5,216,000)
Net cash used for investing activities   41,000 (4,317,000)
Cash flows from financing activities:      
Cash paid on fractional shares on preferred stock conversion to common stock   (2,000)  
Purchase of treasury stock (13,454,000) (3,909,000)  
Payment to repurchase series B preferred stock   (402,000)  
Cash dividends paid (7,118,000) (7,194,000) (4,749,000)
Net cash from financing activities (20,572,000) (11,507,000) (4,749,000)
Net change in cash and cash equivalents (4,643,000) 4,411,000 (10,230,000)
Cash and cash equivalents at beginning of year 24,089,000 19,678,000 29,908,000
Cash and cash equivalents at end of year $ 19,446,000 $ 24,089,000 $ 19,678,000